SC 13G/A

SCHEDULE 13G HOLDINGS REPORT AMENDMENT

Company: Viking Therapeutics, Inc.
Filed: October 10, 2019
Accession Number: 0001172661-19-002034

View Document ↗ View on SEC.gov ↗